G01N 2800/70
Mechanisms involved in disease identification
Official title: Mechanisms involved in disease identification (G01N2800/02 - G01N2800/44 take precedence)
G01N2800/70 (Mechanisms involved in disease identification) appears on 1,030 US grants and 2,235 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,030
- Published applications
- 2,235
- Assignees
- 1,165
- Inventors
- 4,690
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 9 |
| 2005 | 1 | 3 |
| 2006 | 0 | 4 |
| 2007 | 2 | 6 |
| 2008 | 2 | 7 |
| 2009 | 1 | 11 |
| 2010 | 4 | 30 |
| 2011 | 3 | 15 |
| 2012 | 4 | 53 |
| 2013 | 16 | 60 |
| 2014 | 25 | 122 |
| 2015 | 47 | 163 |
| 2016 | 69 | 201 |
| 2017 | 72 | 164 |
| 2018 | 107 | 194 |
| 2019 | 99 | 172 |
| 2020 | 123 | 188 |
| 2021 | 99 | 185 |
| 2022 | 87 | 145 |
| 2023 | 76 | 160 |
| 2024 | 72 | 133 |
| 2025 | 71 | 125 |
| 2026 | 49 | 82 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2800/7023ProliferationIndexing code417
- G01N 2800/7095InflammationIndexing code213
- G01N 2800/7004StressIndexing code105
- G01N 2800/7057Signaling and trafficking pathwaysIndexing code57
- G01N 2800/7047Fibrils-filaments-plaque formationIndexing code55
- G01N 2800/7014Vascularisation - angiogenesisIndexing code50
- G01N 2800/7042AgingIndexing code40
- G01N 2800/709Toxin inducedIndexing code39
Recent patents
- Methods for selecting and treating cancer with FGFR3 inhibitors29 Sep 2026US 12,748,103 B2GeneCentric Therapeutics, Inc.
- POCT diagnostic system for traumatic brain injuries and infectious diseases29 Sep 2026US 12,748,108 B2Ezdiatech Inc.
- Reagent composition for immunophenotyping of B lymphoblastic leukemia/lymphoma and use thereof8 Sep 2026US 12,730,107 B2
- Artificial intelligence for early cancer detection8 Sep 2026US 12,730,108 B2Regents of the University of Minnesota
- Microfluidic-based device for in vivo wound infection model and uses thereof25 Aug 2026US 12,716,889 B2City Unversity of Hong Kong
- Detection of tumor-derived nucleic acids using red blood cells8 Oct 2026US 2026/0308689 A1
- A 1,5-dihydro-4h-pyrrolo[3,2-c] pyridin-4-one for use in the treatment of cancer1 Oct 2026US 2026/0297088 A1Antares Therapeutics, Inc.
- Method for non-invasive hypoxia detection24 Sep 2026US 2026/0287579 A1BioVentures, LLC
- Methods for predicting and improving therapeutic efficacy of cancer treatments and methods for cancer prognosis17 Sep 2026US 2026/0276643 A1
- Non-invasive assay for detecting and monitoring systemic inflammation17 Sep 2026US 2026/0276654 A1Ichilov Tech Ltd.
Most cited
By later US patents
- System, device and method for high-throughput multi-plexed detection116US 9,188,586 B2Yale University · 2015
- Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers93US 10,253,077 B2Immatics Biotechnologies GmbH · 2019
- Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers83US 10,377,802 B2Immatics Biotechnologies GmbH · 2019
- Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy68US 9,943,570 B2Technische UniversitäT Dresden · 2018
- Dual variable domain immunoglobulins and uses thereof65US 8,735,546 B2AbbVie Inc. · 2014